Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin's Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes.
Fumika ShigiyamaShigenori HirumaShinji HisatakeNobuyuki ShiragaTakanori IkedaTakahisa HiroseNaoki KumashiroPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
University Hospital Medical Information Network Clinical Trial Registry: UMIN000026340.